Apollo Hospitals shares in focus as subsidiary raises stake in Keimed for Rs 625 crore

[hfe_template id='11223'] [ad_1]
Apollo Hospitals shares will be in focus on Monday after its subsidiary, Apollo Healthco (AHL), announced plans to acquire an additional 11.2% stake in Keimed Pvt Ltd for Rs 625.43 crore from promoter Shobana Kamineni.

In a regulatory filing, Apollo Hospitals stated that its board had approved AHL’s acquisition of 11.2% of Keimed’s issued and paid-up share capital in two tranches. The purchase will be made from Shobana Kamineni, a related party, for Rs 625.43 crore.


Additionally, AHL will invest Rs 99.99 crore in Keimed as a primary investment, as per the terms of a framework agreement executed among AHL, Keimed, and Keimed’s shareholders.

Also Read: Stocks in news: Adani Green, Adani Enterprises, NCC, Godrej Properties, Max Healthcare

Apollo Hospitals Q3 earnings


Apollo Hospitals reported a 52% year-on-year (YoY) increase in its consolidated net profit, reaching Rs 372 crore for the December 2024 quarter, driven by higher sales. The company had posted a net profit of Rs 245 crore in the same period of the previous fiscal year.

Also Read:Can Bitcoin drop to $20K if Nasdaq falls into a bear market?

Apollo Hospitals shares target price


As per Trendlyne data, the average target price of the stock is Rs 7,814, which shows an upside of 18% from the current market prices. The consensus recommendation from 29 analysts for the stock is a 'Buy'.

Technically, the stock's relative strength index (RSI) is at 63.3. According to Trendlyne, an RSI below 30 is considered oversold, while above 70 indicates overbought conditions. Additionally, the MACD is at -101.1, which is below its center line, this is a bearish indicator.

Apollo Hospitals shares are trading above their 5-day, 10-day, 20-day, 30-day, and 50-day simple moving averages (SMAs) but remain below the 100-day, 150-day, and 200-day SMAs.

Apollo Hospitals shares performance


On Friday, Apollo Hospitals shares closed at Rs 6,621.5, rising 2.3% on the BSE, while the benchmark Sensex gained 0.73%. The stock has declined 10% year-to-date but gained 55% over the last two years. The company’s market capitalization stands at Rs 95,207 crore.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)

[ad_2] Source link https://mrgaga.in/apollo-hospitals-shares-in-focus-as-subsidiary-raises-stake-in-keimed-for-rs-625-crore/?feed_id=47583&_unique_id=67e0e0f93b770

Comments

Post a Comment

Popular posts from this blog

India VIX jumps 100% in one month. Could fear levels take Nifty further down?

Image
[hfe_template id='11223'] [ad_1] Volatility in Indian equity markets has surged sharply over the past month, with the India VIX nearly doubling as geopolitical tensions and global uncertainty triggered aggressive selling in equities. India VIX, often referred to as the market’s fear gauge, has jumped close to 100% over the past month, reflecting growing nervousness among investors. The spike has coincided with a sharp correction in the broader market, with the Nifty 50 declining about 8% during the same period. The escalation of tensions involving the United States, Israel and Iran has intensified market anxiety in recent days, pushing crude oil prices sharply higher and triggering a global risk-off sentiment. However, analysts note that volatility had already been building even before the conflict escalated, reflecting broader concerns around global growth, foreign capital outflows and stretched valuations in equities. The heightened uncertainty translated into a sharp ...
Read more

Can Sensex, Nifty snap 2-day fall on Monday? 7 factors that could decide market mood this week

Image
[hfe_template id='11223'] [ad_1] Benchmark indices Sensex and Nifty ended the week on a bearish note, closing over a percent lower each as a deepening selloff in IT stocks rattled investor sentiment amid mounting fears of AI-led disruption. Further, stronger-than-expected jobs data for January dampened hopes of a US Fed interest rate cut. Here are 7 factors that could decide market action in the coming week: 1.) Infosys, Wipro ADRs rebound - After a brutal two-day selloff that saw Infosys and Wipro ADRs plunge as much as 14.5%, Friday’s session brought a much-needed breather. Bargain hunting kicked in at lower levels, sparking a sharp rebound as Infosys climbed 3% while Wipro gained 4%—helping both stocks close the week on a far stronger note. International brokerage firm JP Morgan has a message for panic-stricken investors: IT services firms are the indispensable "plumbers of the tech world" and their dividend yields have now hit levels last seen only during ...
Read more

Waaree Energies shares in focus after Q4 profit rises 34% to Rs 619 crore, revenue up 36%

Image
[hfe_template id='11223'] [ad_1] Waaree Energies shares will be in focus on Wednesday after the solar panel maker reported a strong Q4 performance, with net profit rising 34.1% year-on-year (YoY) to Rs 618.9 crore for the quarter ended March 31, 2025. In the same quarter last year, the company had reported a profit of Rs 461.5 crore. Revenue from operations jumped 36.4% to Rs 4,003.9 crore, up from Rs 2,935.8 crore in the year-ago period, according to the company’s regulatory filing. EBITDA more than doubled to Rs 922.6 crore in Q4 FY25, up 120.6% from Rs 418.3 crore in the same quarter last year. The EBITDA margin improved to 23% from 14.3% a year ago. The company produced 2.06 GW of solar modules in the fourth quarter, up from 1.35 GW in the same period last year. For the full year, module production reached 7.13 GW, compared to 4.77 GW in FY24. For the full financial year FY25, revenue rose 27.62% YoY to Rs 14,846.06 crore. Profit after tax more than doubled to Rs 1,9...
Read more